Showing 431-440 of 2266 results for "".
Toward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Maintenance of Certification
https://practicalneurology.com/columns/practice-management/maintenance-of-certification/30134/Do we have a certified crisis in medicine?Sleep Medicine: A Team Sport
https://practicalneurology.com/diseases-diagnoses/sleep/sleep-medicine-a-team-sport/30262/The effectiveness of the team will be reflected in the effectiveness of treatment.Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-telemedicine-and-multiple-sclerosis/30116/Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.Accelerating Dementia Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/accelerating-dementia-care/30261/Breaking through barriers to timely, team-based care depends on finding biomarkers and effective treatments.The Digital Future of Cognitive Screening
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-digital-future-of-cognitive-screening/30395/As continued research elucidates Alzheimer's disease biomarkers, cognitive screening tools will play an integral role in the early detection of impairment.Niche No Longer: Bringing Sleep Medicine to the Forefront of Neurological Practice
https://practicalneurology.com/diseases-diagnoses/sleep/niche-no-longer-bringing-sleep-medicine-to-the-forefront-of-neurological-practice/30415/Emerging insights in the realm of sleep are shaping new understandings of neurological diseases.Clarifying the Role of Amyloid Burden in Vascular Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clarifying-the-role-of-amyloid-burden-in-vascular-cognitive-impairment/30466/New evidence suggests that amyloid burden plays a role in the progression of vascular cognitive impairment, particularly in older patients.